18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)

Medicine & Life Sciences

• Adenocarcinoma 5%
• Bone and Bones 4%
• Bone Marrow 10%
• Brain 3%
• Carcinoma 9%
• Cost-Benefit Analysis 6%
• Drug Therapy 8%
• Epithelial Cells 5%
• Fluorodeoxyglucose F18 67%
• Head 5%
• Histology 5%
• Lung Neoplasms 5%
• Neck 10%
• Neoplasm Metastasis 8%
• Neoplasms 4%
• Non-Small Cell Lung Carcinoma 6%
• Pericardium 7%
• Pleura 8%
• Positron-Emission Tomography 59%
• Prospective Studies 4%
• Radiotherapy 9%
• Signet Ring Cell Carcinoma 10%
• Skin 3%
• Therapeutics 3%
• Thoracic Wall 7%
• Tongue 6%
• Unknown Primary Neoplasms 100%
• Unnecessary Procedures 9%